Breaking

Danaher Plans AI-Powered Autonomous Lab for Antibody Discovery in 2027

October 7, 2026 at 14:18 EDT

AI Agents
Healthcare
Robotics

Danaher said it plans to launch its first AI-powered autonomous lab, aiming to speed the development of custom antibodies and other molecular tools by combining AI, robotics and connected life-sciences instruments. The company says the lab is expected to operate at scale in early 2027 and is designed to move researchers from idea to validated affinity reagent up to 8x faster.

Oct. 7, 2026 · Danaher

An AI-and-robotics lab for antibody discovery

Danaher plans an autonomous lab at Abcam that designs, builds and tests affinity reagents in a connected design-make-test-learn loop. The company says the system is expected to operate at scale in early 2027.

The headline number: up to 8x faster discovery

Current cycle

Target acceleration

The company says faster experimental loops should move researchers from idea to validated affinity reagent sooner.

2027

Expected scale operation

10x

Potential annual reagent generation increase

Danaher operating companies named in the workflow

How the loop works

Design

AI proposes affinity reagents.

→

Build

Robotics and instruments make candidates.

→

Test

Each design is verified experimentally.

→

Learn

Results feed back into the model.

Why it matters

A closed loop could connect computational design directly to wet-lab validation for antibodies and other molecular tools.

What remains unproven

The lab is not yet operating at scale, and the speed and output targets are still forward-looking claims.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.